BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14740449)

  • 1. Active MMPs captured by alpha 2 macroglobulin as a marker of disease activity in rheumatoid arthritis.
    Tchetverikov I; Verzijl N; Huizinga TW; TeKoppele JM; Hanemaaijer R; DeGroot J
    Clin Exp Rheumatol; 2003; 21(6):711-8. PubMed ID: 14740449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis.
    Tchetverikov I; Ronday HK; Van El B; Kiers GH; Verzijl N; TeKoppele JM; Huizinga TW; DeGroot J; Hanemaaijer R
    Ann Rheum Dis; 2004 Jul; 63(7):881-3. PubMed ID: 15194590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorogenic MMP activity assay for plasma including MMPs complexed to alpha 2-macroglobulin.
    Beekman B; Drijfhout JW; Ronday HK; TeKoppele JM
    Ann N Y Acad Sci; 1999 Jun; 878():150-8. PubMed ID: 10415727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik B; Skowronski J; Chwiecko J
    Rheumatology (Oxford); 2002 Jan; 41(1):78-87. PubMed ID: 11792884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leflunomide and methotrexate reduce levels of activated matrix metalloproteinases in complexes with alpha2 macroglobulin in serum of rheumatoid arthritis patients.
    Tchetverikov I; Kraan MC; van El B; Hanemaaijer R; DeGroot J; Huizinga TW
    Ann Rheum Dis; 2008 Jan; 67(1):128-30. PubMed ID: 17875551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between tumor necrosis factor alpha and matrix metalloproteinases levels in serum of patients with rheumatic arthritis].
    Klimiuk PA; Sierakowski S; Chwiećko J
    Pol Merkur Lekarski; 2003 May; 14(83):410-2. PubMed ID: 12939814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase protein expression profiles cannot distinguish between normal and early osteoarthritic synovial fluid.
    Heard BJ; Martin L; Rattner JB; Frank CB; Hart DA; Krawetz R
    BMC Musculoskelet Disord; 2012 Jul; 13():126. PubMed ID: 22824140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
    Vandooren B; Kruithof E; Yu DT; Rihl M; Gu J; De Rycke L; Van Den Bosch F; Veys EM; De Keyser F; Baeten D
    Arthritis Rheum; 2004 Sep; 50(9):2942-53. PubMed ID: 15457463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
    Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
    Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of serum matrix metalloproteinases and their tissue inhibitor levels with scleroderma disease severity.
    Toubi E; Kessel A; Grushko G; Sabo E; Rozenbaum M; Rosner I
    Clin Exp Rheumatol; 2002; 20(2):221-4. PubMed ID: 12051403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis.
    Tchetverikov I; Lard LR; DeGroot J; Verzijl N; TeKoppele JM; Breedveld FC; Huizinga TW; Hanemaaijer R
    Ann Rheum Dis; 2003 Nov; 62(11):1094-9. PubMed ID: 14583574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
    Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.
    Connolly M; Mullan RH; McCormick J; Matthews C; Sullivan O; Kennedy A; FitzGerald O; Poole AR; Bresnihan B; Veale DJ; Fearon U
    Arthritis Rheum; 2012 Apr; 64(4):1035-45. PubMed ID: 22076945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis.
    Tchetverikov I; Lohmander LS; Verzijl N; Huizinga TW; TeKoppele JM; Hanemaaijer R; DeGroot J
    Ann Rheum Dis; 2005 May; 64(5):694-8. PubMed ID: 15834054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum MMPs 7-9 and their inhibitors during glucocorticoid and anti-TNF-α therapy in pediatric inflammatory bowel disease.
    Mäkitalo L; Rintamäki H; Tervahartiala T; Sorsa T; Kolho KL
    Scand J Gastroenterol; 2012 Jul; 47(7):785-94. PubMed ID: 22519363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis.
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Gindzienska-Sieskiewicz E; Chwiecko J
    J Rheumatol; 2006 Aug; 33(8):1523-9. PubMed ID: 16881109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of α-defensin-1 and related signal transduction mechanisms in the production of IL-6, IL-8 and MMPs in rheumatoid fibroblast-like synoviocytes.
    Ahn JK; Huang B; Bae EK; Park EJ; Hwang JW; Lee J; Koh EM; Cha HS
    Rheumatology (Oxford); 2013 Aug; 52(8):1368-76. PubMed ID: 23620556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of a chromogenic substrate by alpha 2-macroglobulin from plasma of patients with rheumatoid arthritis.
    Teodorescu M; Gaspar A; Spear G; Skosey JL; Ganea D
    Arthritis Rheum; 1984 Oct; 27(10):1122-9. PubMed ID: 6207846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of alpha 2-macroglobulin-associated proteases in the plasma of patients with rheumatoid arthritis.
    Gaspar A; Skosey JL; Sequeira W; Teodorescu M
    Clin Chem; 1984 Sep; 30(9):1517-22. PubMed ID: 6205792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.